(MedPage Today) — BETHESDA, Md. — An FDA advisory committee has voted narrowly — 8 to 6 — to recommend that the agency expand the indication for the antidepressant duloxetine (Cymbalta) to treat chronic musculoskeletal pain.
No Comments »
Filed under: General Health News
(MedPage Today) — More teens are receiving their adolescent vaccines for diseases including tetanus, meningitis, and human papillomavirus virus (HPV), CDC researchers say.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — A voluntary recall of eggs from several brands and distributed across multiple states has expanded to include additional dates and plant numbers following confirmed Salmonella enteritidis cases from the eggs.
No Comments »
Filed under: General Health News
(MedPage Today) — Maternal exposure to organophosphate pesticides such as diazinon during pregnancy was correlated with ADHD symptoms in their children five years later, researchers said.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — Medicare beneficiaries enrolled in the Part D will pay an average of $30 per month for their prescription drug benefit premiums in 2011, a $1 increase over what they paid this year, Centers for Medicare and Medicaid Services (CMS) officials said.
No Comments »
Filed under: General Health News
(MedPage Today) — BETHESDA, Md. — An FDA advisory committee has voted narrowly — 8 to 6 — to recommend that the agency expand the indication for the antidepressant duloxetine (Cymbalta) to treat chronic musculoskeletal pain.
No Comments »
Filed under: Pharmacy News
Advaxis, Inc.,the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, has completed the nine (9) doses to be administered to the three (3) vanguard patients in the low dose group of its phase II cervical dysplasia clinical trial study.
No Comments »
Filed under: Pharmacy News
ImmunoGen, Inc., a biotechnology company that develops antibody-based targeted anticancer products, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its lorvotuzumab mertansine (formerly IMGN901) product candidate when used for the treatment of small-cell lung cancer (SCLC).
No Comments »
Filed under: Pharmacy News
Bolder BioTechnology, Inc. today announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant totaling $600,000 from the National Institute of Allergy and Infectious Diseases (NIAID) of The National Institutes of Health (NIH). The grant will be used to demonstrate the feasibility of using our novel, long-acting IL-11 analog [...]
No Comments »
Filed under: Pharmacy News
Neurological and infectious disease experts at Rush University Medical Center are testing a new drug therapy for the treatment of individuals with West Nile fever or suspected central nervous system infection due to the West Nile virus. Rush is the only site in the Midwest enrolling patients into the $50 million dollar, NIH-funded, Phase II [...]
No Comments »
Filed under: Pharmacy News
